Martin O. Weickert

11.7k total citations · 5 hit papers
178 papers, 8.1k citations indexed

About

Martin O. Weickert is a scholar working on Physiology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Martin O. Weickert has authored 178 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 62 papers in Epidemiology and 54 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Martin O. Weickert's work include Diet and metabolism studies (40 papers), Neuroendocrine Tumor Research Advances (29 papers) and Regulation of Appetite and Obesity (27 papers). Martin O. Weickert is often cited by papers focused on Diet and metabolism studies (40 papers), Neuroendocrine Tumor Research Advances (29 papers) and Regulation of Appetite and Obesity (27 papers). Martin O. Weickert collaborates with scholars based in United Kingdom, Germany and United States. Martin O. Weickert's co-authors include Andreas Pfeiffer, Thomas M. Barber, Matthias Möhlig, Stefan Kabisch, Joachim Spranger, Harpal Randeva, Vera Regitz‐Zagrosek, Elke Lehmkuhl, Ayman M. Arafat and Martin Osterhoff and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Martin O. Weickert

173 papers receiving 7.9k citations

Hit Papers

The Health Benefits of Di... 2008 2026 2014 2020 2020 2008 2018 2019 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin O. Weickert United Kingdom 46 2.8k 2.2k 1.7k 1.7k 1.5k 178 8.1k
Matthias Möhlig Germany 42 2.5k 0.9× 1.9k 0.9× 1.9k 1.1× 2.7k 1.6× 771 0.5× 111 7.6k
Barbora de Courten Australia 44 2.6k 0.9× 1.7k 0.8× 1.2k 0.7× 1.0k 0.6× 1.0k 0.7× 180 7.0k
Thomas M. Badger United States 64 1.8k 0.6× 2.2k 1.0× 3.3k 1.9× 1.9k 1.1× 955 0.6× 324 12.4k
Husam Ghanim United States 53 2.8k 1.0× 4.0k 1.8× 2.5k 1.4× 3.2k 1.9× 554 0.4× 116 10.9k
Ahmad Aljada United States 47 2.3k 0.8× 3.1k 1.4× 2.5k 1.4× 3.9k 2.3× 716 0.5× 127 10.4k
Kieren J. Mather United States 44 2.6k 0.9× 4.5k 2.1× 2.2k 1.3× 1.9k 1.1× 940 0.6× 186 10.5k
Li‐Qiang Qin China 49 2.2k 0.8× 837 0.4× 1.5k 0.8× 698 0.4× 2.1k 1.4× 258 8.0k
A. B. Jenkins Australia 46 5.0k 1.8× 2.3k 1.0× 2.8k 1.6× 1.7k 1.0× 675 0.4× 114 9.0k
Priya Mohanty United States 33 1.9k 0.7× 2.4k 1.1× 1.5k 0.9× 2.6k 1.5× 464 0.3× 45 7.3k
Bjørn Richelsen Denmark 57 5.2k 1.9× 2.6k 1.2× 1.9k 1.1× 4.4k 2.6× 768 0.5× 185 10.6k

Countries citing papers authored by Martin O. Weickert

Since Specialization
Citations

This map shows the geographic impact of Martin O. Weickert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin O. Weickert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin O. Weickert more than expected).

Fields of papers citing papers by Martin O. Weickert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin O. Weickert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin O. Weickert. The network helps show where Martin O. Weickert may publish in the future.

Co-authorship network of co-authors of Martin O. Weickert

This figure shows the co-authorship network connecting the top 25 collaborators of Martin O. Weickert. A scholar is included among the top collaborators of Martin O. Weickert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin O. Weickert. Martin O. Weickert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khan, Mohid S., Kathryn Cook, Martin O. Weickert, et al.. (2024). PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK. Supportive Care in Cancer. 32(3). 199–199. 2 indexed citations
3.
Leerdam, Monique E. van, Margot Tesselaar, Parthi Srinivasan, et al.. (2024). High Prevalence of Sarcopenia in Patients with Newly Diagnosed Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs), but No Association with the Risk of Surgical Complications. Nutrients. 16(22). 3790–3790. 1 indexed citations
4.
Leerdam, Monique E. van, Margot Tesselaar, Wendy Martin, et al.. (2024). The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours. Journal of Neuroendocrinology. 36(4). e13376–e13376. 7 indexed citations
5.
Tsoli, Marina, Kosmas Daskalakis, Anna Angelousi, et al.. (2023). Pancreatic metastases in patients with neuroendocrine neoplasms: A multi‐centre cohort study. Journal of Neuroendocrinology. 35(4). e13269–e13269. 1 indexed citations
6.
Ali, Danish, Stuart Ennis, Richard Powell, et al.. (2023). Rising Arterial Stiffness with Accumulating Comorbidities Associates with Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 10(4). 2487–2498. 14 indexed citations
7.
Leerdam, Monique E. van, et al.. (2023). Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours. Cancers. 15(3). 782–782. 9 indexed citations
8.
Barber, Thomas M., Stefan Kabisch, Andreas Pfeiffer, & Martin O. Weickert. (2023). Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks. Metabolites. 13(6). 757–757. 8 indexed citations
10.
Ramage, John, Elizabeth Friend, Barbara King, et al.. (2022). Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module). Journal of Neuroendocrinology. 34(4). e13097–e13097. 4 indexed citations
11.
Daskalakis, Kosmas, Marina Tsoli, Raj Srirajaskanthan, et al.. (2022). Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival. Journal of Neuroendocrinology. 34(11). e13205–e13205. 6 indexed citations
12.
Weickert, Martin O., Tim Robbins, Ioannis Kyrou, et al.. (2021). Impact of the COVID-19 pandemic on neuroendocrine tumour services in England. Endocrine. 71(1). 14–19. 5 indexed citations
14.
Kyrou, Ioannis, Sarah Wayte, Dimitris Grammatopoulos, et al.. (2018). Improved Thyroid Hypoechogenicity Following Bariatric-Induced Weight Loss in Euthyroid Adults With Severe Obesity—a Pilot Study. Frontiers in Endocrinology. 9. 488–488. 12 indexed citations
15.
Weickert, Martin O., Gregory Kaltsas, Dieter Hörsch, et al.. (2018). Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period. Pancreas. 47(3). 341–342. 2 indexed citations
16.
Burch, Nicola, Maralyn Druce, John Hattersley, et al.. (2016). Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study. BMJ Open. 6(5). e010765–e010765. 39 indexed citations
17.
Pivovarova‐Ramich, Olga, Özlem Gögebakan, Nora Klöting, et al.. (2012). Insulin Up-Regulates Natriuretic Peptide Clearance Receptor Expression in the Subcutaneous Fat Depot in Obese Subjects: A Missing Link between CVD Risk and Obesity?. The Journal of Clinical Endocrinology & Metabolism. 97(5). E731–E739. 68 indexed citations
18.
Pivovarova‐Ramich, Olga, Eva Fisher, Iryna Ilkavets, et al.. (2011). A polymorphism within the connective tissue growth factor (CTGF) gene has no effect on non-invasive markers of beta-cell area and risk of type 2 diabetes.. PubMed. 31(4). 241–6. 7 indexed citations
19.
Loeffelholz, Christian von, Matthias Möhlig, Ayman M. Arafat, et al.. (2009). Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. European Journal of Endocrinology. 162(3). 507–513. 61 indexed citations
20.
Weickert, Martin O., et al.. (2009). A reverse postural test as a screening tool for aldosterone-producing adenoma: a pilot study. Endocrine. 36(1). 75–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026